Sumitomo Pharma Co Ltd
XMUN:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
XMUN:DPM
|
JP |
|
A
|
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
|
TH |
|
H
|
Harvey Norman Holdings Ltd
F:HNN
|
AU |
Wall St Price Targets
DPM Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DPM is 11.057 EUR with a low forecast of 8.35 EUR and a high forecast of 15.047 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
11.057
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 11.057 EUR with a low forecast of 8.35 EUR and a high forecast of 15.047 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-83%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is -83%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is -4%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-14%
Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -14%.
